Blood Tests for Rheumatoid Arthritis
The full panel Australian GPs and rheumatologists use to diagnose and monitor rheumatoid arthritis: anti-CCP, rheumatoid factor, inflammatory markers, and the safety bloods required before treatment.
Free to use · No credit card · Works with any Australian lab
· · Reviewed against the sources listed at the end of this page.
The Quick Answer
There is no single blood test that diagnoses rheumatoid arthritis (RA). Doctors use a panel: anti-CCP (anti-cyclic citrullinated peptide, also reported as ACPA) is the most specific test and often predicts the more erosive form of the disease. Rheumatoid factor (RF) is more sensitive but far less specific. CRP and ESR track inflammation and disease activity, and a full blood count can show the anaemia and raised platelet count that go with active disease.
If you already have a single rheumatoid factor result and want to understand just that number, our dedicated positive rheumatoid factor guide covers that in isolation. This page is broader: it walks through the whole panel used to diagnose and then monitor RA over time, including the safety bloods needed before treatment starts.
The key point to hold onto: roughly 20 to 30 percent of genuine rheumatoid arthritis is seronegative, meaning both RF and anti-CCP are negative. A negative blood panel never rules RA out. Diagnosis rests on the whole picture: symptoms, joint examination, blood tests, and imaging together.
Typical Australian Reference Ranges
Exact cut-offs vary by laboratory and assay, always check the range printed on your own report. As a general guide for Australian adults:
Rheumatoid factor (RF)
Negative below approximately 20 IU/mL (some labs use 0-14 IU/mL). A result more than three times the upper limit counts as strongly positive in classification scoring.
Anti-CCP (ACPA)
Negative below approximately 20 U/mL (assay-dependent). Low-positive and high-positive (over three times the upper limit) are reported separately because high-positive results carry more diagnostic weight.
CRP
Normal is generally below 5 mg/L (some labs use below 3 mg/L). Levels rise and fall quickly with disease activity.
ESR
Age and sex dependent. A common rule of thumb is age divided by 2 for men, and (age plus 10) divided by 2 for women, in mm/hr. Typically under 20 mm/hr in a healthy younger adult.
Serum urate
Approximately 0.20 to 0.42 mmol/L in men and 0.15 to 0.35 mmol/L in women. Checked to exclude gout as a mimic of RA, ideally when the joint is not actively flaring.
ANA
Reported as a titre (for example 1:80, 1:160). Low positive titres are common in the general population and in RA itself, and are not diagnostic of lupus alone.
The Full RA Blood Test Panel
Each test in the panel answers a different question. Read together, they are far more useful than any one result in isolation.
Anti-CCP (ACPA)
The most specific antibody test for rheumatoid arthritis, roughly 95 to 98 percent specific.
Often positive years before joint symptoms appear, and a positive result predicts more erosive, aggressive disease. Sensitivity is around 60 to 70 percent, so a negative result does not exclude RA.
Rheumatoid factor (RF)
A more sensitive but far less specific antibody, roughly 60 to 70 percent sensitive, 70 to 85 percent specific.
Positive in about 5 percent of healthy people, rising with age. Also seen in Sjogren syndrome, hepatitis C, chronic infection, and lung disease, so a positive result is not diagnostic on its own.
CRP
A fast-responding acute-phase marker of inflammation, used to track disease activity and treatment response.
Can be normal even in active early RA, so a normal CRP never excludes the diagnosis. Rises and falls faster than ESR, useful for monitoring flares.
ESR
A slower, non-specific marker of inflammation, affected by age, sex, and anaemia.
Used alongside CRP in disease activity scores. Like CRP, it can sit within the normal range during genuinely active RA, particularly early or seronegative disease.
Full blood count (FBC)
Shows anaemia of chronic disease (mild, normocytic) and reactive thrombocytosis (raised platelets) from ongoing inflammation.
A low haemoglobin with a raised platelet count and raised CRP is a classic supportive pattern in active RA. Also used as a safety baseline before starting DMARDs.
ANA
Screens for lupus and overlap connective tissue disease, not for RA itself.
Positive at low titre in roughly 30 to 40 percent of RA patients without lupus, so a low-titre positive alone is not concerning. Ordered when there are atypical features such as rash, photosensitivity, or kidney involvement.
Serum urate
Excludes gout as a mimic, especially with chronic tophaceous gout that can look polyarticular like RA.
Urate can be misleadingly normal or low during an acute flare because urate is being deposited into tissue. Best checked when the joint is quiet, not mid-flare.
Already got your RF, anti-CCP, CRP, or ESR result back?
Upload your pathology report and SmarterBlood's AI will explain each result against Australian reference ranges, in plain English, in under a minute.
Upload Your Results FreeAnti-CCP: The Most Specific Test
Anti-CCP antibodies (anti-cyclic citrullinated peptide, reported by some labs as ACPA, anti-citrullinated protein antibody) target proteins that have been chemically altered by a process called citrullination. This process happens in inflamed joint tissue, and the immune system in people who go on to develop RA often reacts to it abnormally.
Anti-CCP is roughly 95 to 98 percent specific for rheumatoid arthritis, meaning a positive result is rarely explained by anything else. Its sensitivity is lower, around 60 to 70 percent, so a negative anti-CCP does not exclude RA. What makes it particularly useful clinically is timing: anti-CCP can turn positive up to ten years before the first joint symptoms appear, and a positive result predicts a more erosive disease course, meaning earlier, more permanent joint damage if treatment is delayed.
Because of this, a strongly positive anti-CCP in someone with new joint swelling is taken seriously even before the rest of the workup is complete, and tends to push referral and treatment decisions to happen sooner rather than waiting to see how symptoms evolve.
Rheumatoid Factor: Sensitive but Poorly Specific
Rheumatoid factor is an antibody directed against the tail end (the Fc portion) of a person's own IgG antibodies. It has been used to support an RA diagnosis for decades and remains part of the standard panel, but on its own it is too non-specific to settle the question either way.
Around 5 percent of healthy people carry a positive rheumatoid factor with no joint disease at all, and that background rate climbs further with age, so an incidental positive RF in someone over 65 is common and often meaningless on its own. RF is also positive in a range of conditions that have nothing to do with RA:
- Sjogren syndrome (often at very high titre)
- Chronic hepatitis C infection
- Subacute bacterial endocarditis and other chronic infections, including tuberculosis
- Interstitial lung disease and pulmonary fibrosis
- Sarcoidosis and cryoglobulinaemia
- Systemic lupus erythematosus and other connective tissue overlaps
For this reason, an isolated positive RF without joint swelling is not a reason to start treating for rheumatoid arthritis. It is a prompt to look at the whole clinical picture, and to check anti-CCP alongside it, since the combination of both antibodies is far more informative than either alone. If you only have an RF result and no other symptoms, our single-marker rheumatoid factor guide walks through what to do next.
Seronegative Rheumatoid Arthritis
Roughly 20 to 30 percent of people with genuine rheumatoid arthritis have both rheumatoid factor and anti-CCP negative, at diagnosis and often for the life of the disease. This is called seronegative RA, and it is a real, recognised subtype, not a sign that the diagnosis is wrong.
In seronegative disease, the diagnosis rests on the clinical and imaging picture: symmetric small joint swelling, morning stiffness lasting more than 30 to 60 minutes, elevated CRP or ESR (though these can also be normal), and ultrasound or MRI findings of synovitis or early erosion that are not yet visible on a plain X-ray. Formal classification criteria (the ACR/EULAR 2010 criteria) score joint involvement, serology, acute phase reactants, and symptom duration together, so a person can still score highly enough for a confident diagnosis with completely negative bloods.
Inflammatory Markers and the Full Blood Count
CRP and ESR: useful, but not reliably exclusionary
CRP and ESR are both acute-phase markers that rise with inflammation anywhere in the body, not specifically in the joints, and are used to track how active the disease is over time and whether treatment is working. The catch is that in active early rheumatoid arthritis, both can sit comfortably within the normal range. Studies of early inflammatory arthritis clinics consistently find a meaningful proportion of confirmed RA patients with a normal CRP and ESR at presentation. A normal result is not reassuring when the joint examination points to inflammatory arthritis.
Full blood count: anaemia and reactive thrombocytosis
Active rheumatoid arthritis commonly produces a mild anaemia of chronic disease: normocytic (normal-sized red cells), with normal or high ferritin despite low serum iron, distinguishing it from true iron deficiency. Platelets are often mildly to moderately raised (reactive thrombocytosis) as part of the acute-phase response, the opposite pattern to lupus, where platelets and white cells are more often low. A rare but important combination is Felty syndrome, longstanding seropositive RA with an enlarged spleen and a low neutrophil count, which increases infection risk and needs specialist input.
Ruling Out Mimics: ANA and Urate
ANA: screening for lupus and overlap
Antinuclear antibody (ANA) is checked when there are features that would not be explained by RA alone, such as a facial rash, sensitivity to sunlight, unexplained kidney involvement, or symptoms in multiple organ systems. A positive ANA at low titre is common in RA itself (and in the healthy population) and does not by itself mean lupus. A high titre alongside specific antibodies (such as anti-dsDNA) points more strongly towards lupus or an overlap syndrome and changes the treatment plan significantly, so it is worth checking when the clinical picture is not a clean fit for RA alone.
Serum urate: excluding gout
Gout classically affects a single joint, most often the big toe, but chronic tophaceous gout can affect multiple small joints of the hands in a pattern that can superficially resemble RA, particularly in older patients or those with kidney disease. A raised serum urate supports gout as the explanation, but urate can be falsely normal or even low during an acute flare, so it is best interpreted alongside joint fluid analysis or checked again once the flare has settled. See our dedicated guide on blood tests for gout for the full picture.
Baseline Safety Bloods Before Treatment
Before starting a disease-modifying drug, your rheumatologist confirms it is safe to suppress part of your immune response. This baseline panel and ongoing monitoring schedule is standard practice across Australian rheumatology services.
Methotrexate
Baseline: FBC, liver function tests (including albumin), renal function/eGFR, hepatitis B and C serology, TB screen (IGRA, e.g. QuantiFERON), pregnancy test if relevant.
Ongoing monitoring: FBC and LFTs every 2 to 4 weeks until the dose is stable, then every 8 to 12 weeks long term.
Watch for: Rising ALT/AST, falling white cell or platelet count, unexplained mouth ulcers, breathlessness or dry cough (possible pneumonitis).
Leflunomide
Baseline: FBC, LFTs, blood pressure, hepatitis B and C serology. Teratogenic, so pregnancy must be excluded and a washout procedure used before conception.
Ongoing monitoring: FBC and LFTs monthly for the first 6 months, then every 6 to 8 weeks.
Watch for: Rising liver enzymes, new hypertension, diarrhoea, unexplained bruising.
Hydroxychloroquine
Baseline: FBC, renal function, LFTs, and a baseline eye examination (retinal toxicity screen, not a blood test) before starting.
Ongoing monitoring: Annual eye screening after 5 years of use (or sooner with kidney disease or high dose); blood tests are less frequent than for methotrexate.
Watch for: Visual changes, muscle weakness (rare cardiomyopathy or myopathy at high cumulative doses).
Biologics (e.g. TNF inhibitors, IL-6 inhibitors)
Baseline: FBC, LFTs, renal function, hepatitis B and C serology, TB screen (IGRA plus chest X-ray), varicella (chickenpox) immunity status.
Ongoing monitoring: FBC and LFTs every 3 to 6 months; annual TB and hepatitis risk reassessment.
Watch for: Any fever or signs of infection (hold the dose and seek review immediately), unexplained bruising, jaundice.
Your rheumatologist may also check hepatitis serology and TB screening once, before the first immunosuppressive drug of any kind, rather than repeating them for each new medication, unless risk factors change. For a broader look at how regular blood monitoring works across long-term medications, see blood tests for medication monitoring.
What Your GP Will Do Next
Confirm the clinical pattern
Your GP examines your joints for synovitis (soft, boggy swelling, not just tenderness), checks whether small joints of the hands, wrists, and feet are affected symmetrically, and asks about morning stiffness lasting more than 30 to 60 minutes. This clinical picture carries as much weight as the blood results.
Order the first-line blood panel
FBC, CRP, ESR, rheumatoid factor, and anti-CCP are usually ordered together. ANA and serum urate are added if lupus overlap or gout are realistic alternatives given the pattern of joints involved.
Arrange imaging
Plain X-rays of the hands and feet look for established erosions, though these are often normal very early in the disease. Ultrasound is increasingly used because it can detect active synovitis before any erosion is visible on X-ray.
Refer to rheumatology urgently if joints are swollen
Any joint swelling lasting more than 6 weeks, or a positive squeeze test across the knuckles or across the ball of the foot, warrants an urgent rheumatology referral regardless of what the blood tests show. Seronegative results are not a reason to wait.
Bridge symptoms while waiting for specialist review
While the referral is pending, your GP may use a short course of low-dose prednisolone or an anti-inflammatory to control symptoms. This is symptom control only, it does not replace disease-modifying treatment and is not started without medical advice.
Baseline safety bloods before disease-modifying treatment
Once rheumatoid arthritis is confirmed, the rheumatologist orders the baseline safety panel (liver, kidney, full blood count, hepatitis and TB screening) before starting methotrexate, leflunomide, hydroxychloroquine, or a biologic, then sets an ongoing monitoring schedule.
When to Seek Urgent Care
A single hot, swollen joint you cannot move, especially with fever
This can be septic arthritis, a joint infection, which is a medical emergency requiring same-day assessment and joint aspiration, not a routine GP appointment.
Breathlessness, a new dry cough, or chest pain while on methotrexate or a biologic
Can indicate drug-induced lung inflammation or a serious chest infection while immunosuppressed. Seek same-day medical review and mention the medication.
Fever, chills, or any sign of infection while on a biologic
Biologics suppress the immune response to infection. Hold the next dose and contact your rheumatology team or GP the same day rather than waiting it out.
Unexplained bruising, bleeding gums, or looking pale and unusually tired on methotrexate
Can signal bone marrow suppression affecting blood cell production. Needs an urgent full blood count, not the next scheduled routine test.
Related Reading
Sources and reference ranges
Adult reference ranges on this page follow the AACB and RCPA harmonised reference intervals unless stated otherwise; the range printed on your own report always takes precedence because laboratories differ.
Blood Tests for Rheumatoid Arthritis: Frequently Asked Questions
What blood tests are used to diagnose rheumatoid arthritis in Australia?
Australian GPs typically order a panel rather than a single test: rheumatoid factor (RF), anti-CCP antibody (also called ACPA), CRP and ESR for inflammation, and a full blood count. Anti-CCP is the most specific test and often predicts more aggressive, erosive disease. RF is more sensitive but far less specific. No single blood result confirms rheumatoid arthritis on its own. Diagnosis combines the blood panel with a joint examination, symptom duration, and often an ultrasound or X-ray of the hands and feet, usually confirmed by a rheumatologist rather than blood tests alone.
Can you have rheumatoid arthritis with a negative rheumatoid factor and negative anti-CCP?
Yes. Around 20 to 30 percent of people with genuine rheumatoid arthritis test negative for both rheumatoid factor and anti-CCP, a pattern called seronegative rheumatoid arthritis. A negative blood panel never rules out RA on its own. If joint swelling, symmetric small joint involvement, and morning stiffness lasting more than 30 to 60 minutes are present, the diagnosis is made clinically and confirmed with imaging (ultrasound or MRI showing synovitis or early erosions), not blood results. Seronegative disease still needs the same urgency of referral and treatment as seropositive RA.
What is the difference between rheumatoid factor and the anti-CCP test?
Rheumatoid factor (RF) is an older, more sensitive but far less specific test: about 5 percent of healthy people carry it, the rate rises with age, and it also appears in Sjogren syndrome, hepatitis C, chronic infection, and interstitial lung disease. Anti-CCP (anti-cyclic citrullinated peptide, also reported as ACPA) is much more specific to rheumatoid arthritis, is often positive years before joint symptoms begin, and predicts a more erosive disease course. Anti-CCP is generally considered the more useful test of the two, though ordering both improves overall diagnostic accuracy.
Is a positive rheumatoid factor always rheumatoid arthritis?
No. A positive rheumatoid factor is common in the general population, especially with age, and does not by itself mean rheumatoid arthritis. It also appears in Sjogren syndrome, systemic lupus erythematosus, chronic hepatitis C infection, subacute bacterial endocarditis, tuberculosis and other chronic infections, sarcoidosis, and some lung fibrosis. RF is best interpreted alongside anti-CCP, inflammatory markers, and the clinical joint examination, never as a stand-alone diagnosis. The strength of the result also matters: a weakly positive RF just above the cut-off carries far less weight than a strongly positive titre, which is why Australian labs report RF as a number in IU/mL next to the reference cut-off rather than simply positive or negative.
What blood tests are needed before starting methotrexate or a biologic for rheumatoid arthritis?
Before starting methotrexate, leflunomide, hydroxychloroquine, or a biologic, your rheumatologist orders baseline liver function tests, renal function (eGFR), a full blood count, hepatitis B and C serology, and a tuberculosis screen (an interferon-gamma release assay such as QuantiFERON, often with a chest X-ray). These confirm it is safe to suppress your immune system. After starting, blood tests are repeated regularly, often every 2 to 4 weeks initially, then every 8 to 12 weeks once the dose is stable, to catch liver, kidney, or bone marrow problems early.
What does a high CRP or ESR mean in rheumatoid arthritis?
CRP and ESR are acute-phase markers that rise with active inflammation and are used to track disease activity and response to treatment. However, both can be completely normal in genuinely active early rheumatoid arthritis, particularly in seronegative or mild disease, so a normal CRP or ESR never excludes RA. When they are elevated alongside joint symptoms, they support ongoing inflammation and are tracked over time (often as part of a disease activity score) to see whether treatment is working, rather than used as a single diagnostic cut-off.
How urgent is a rheumatology referral for suspected rheumatoid arthritis?
Very urgent. Rheumatoid arthritis has a window of opportunity, typically the first 3 to 6 months of symptoms, during which starting disease-modifying treatment gives the best chance of preventing permanent joint erosion and disability. Australian guidelines recommend referring anyone with joint swelling lasting more than 6 weeks, especially in the small joints of the hands or feet, to a rheumatologist urgently rather than waiting for blood results. Many rheumatology services prioritise suspected early inflammatory arthritis referrals for review within 4 to 6 weeks.
Can blood tests alone rule out rheumatoid arthritis?
No. Because 20 to 30 percent of true rheumatoid arthritis is seronegative, and CRP and ESR can be normal even in active early disease, a completely normal blood panel does not exclude the diagnosis. Blood tests are one part of a combined assessment that also includes the pattern and duration of joint symptoms, physical examination for synovitis, and imaging. If your GP or rheumatologist has ongoing clinical suspicion despite normal bloods, further review or imaging is the appropriate next step, not reassurance from the blood panel alone.
Got Your Rheumatoid Arthritis Bloods Back?
Upload your pathology report and SmarterBlood's AI will explain your anti-CCP, RF, CRP, ESR, and full blood count, in plain English, with Australian reference ranges, so you know exactly what to ask your GP.
This page provides general educational information about the blood tests used around rheumatoid arthritis. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your GP or rheumatologist about your own results and joint symptoms, they have access to your full clinical picture and imaging. SmarterBlood does not provide medical care.